Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
placebo vaginal tablet
DRUG
4 trials
Sponsors
CONRAD
, Alfasigma S.p.A.
, Cairo University
Conditions
BACTERIAL VAGINOSIS
HIV
Intrauterine Device
Office Hysteroscopy
Phase 1
Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Completed
NCT01694407
CONRAD
HIV
Start: 2013-02-28
End: 2013-12-31
Updated: 2015-04-03
Phase 2
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Terminated
NCT02376972
Alfasigma S.p.A.
BACTERIAL VAGINOSIS
Start: 2015-04-30
End: 2016-02-29
Updated: 2016-10-10
Phase 3
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
Completed
NCT03686085
Cairo University
Intrauterine Device
Start: 2018-09-30
End: 2019-03-10
Updated: 2020-06-30
Phase 4
Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients
Completed
NCT03683914
Cairo University
Office Hysteroscopy
Start: 2018-09-30
End: 2019-02-28
Updated: 2019-03-26
Related Papers
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
Frontiers in Cellular and Infection Microbiology
2023-04-19
11 citations